Hypnosis used in breast cancer treatment: experiences of women and hypnotherapists as told by them

Share Hypnosis used in breast cancer treatment: experiences of women and hypnotherapists as told by them on Facebook Share Hypnosis used in breast cancer treatment: experiences of women and hypnotherapists as told by them on Twitter Share Hypnosis used in breast cancer treatment: experiences of women and hypnotherapists as told by them on Linkedin Email Hypnosis used in breast cancer treatment: experiences of women and hypnotherapists as told by them link

Consultation has concluded

Hypnosis as a therapy is used across the world every day, it can be used to help cancer related pain, as well as emotional distress and anxiety. In some regions in the UK it can be available through the NHS as a complementary therapy. It is more likely to be funded privately. However we do not have enough good quality evidence on how well it works for patients. We want to further explore the benefits, any potential pitfalls and what place it has in health settings.

This study is about listening to people with experience of hypnosis in breast cancer care in the UK to add to and improve our knowledge on the subject. As a University professional doctorate psychotherapy research study, its aim is to carefully, and sensitively learn about the personal experience of women who have received hypnosis in breast cancer care.

There are two research groups for the study:

Participants, group 1. Women diagnosed with breast cancer who, in the last 5 years, have received hypnosis for cancer related pain (e.g. emotional distress, anxiety, fear, grief, trauma, loss, anguish, etc., and or any physical pain).

Participants, group 2. Hypnotists/hypnotherapists who have used hypnosis in the UK within the last five years for women diagnosed with breast cancer. Specifically for cancer related emotional and or physical pain.

Anonymity for all participants is assured.

Please get in touch with Bryn Higgott at [email protected] if you fit the above criteria and are interested in attending on online interview. Deadline for interviews is 29th February 2024.

(Ethics approval information: UCLan Ethics approval number is: Health 0379FR. The NHS have given Advisory Board approval to proceed as not requiring NHS ethics approval. This has already been supplied to the Ethics Committee and is not required for resubmission.)

Hypnosis as a therapy is used across the world every day, it can be used to help cancer related pain, as well as emotional distress and anxiety. In some regions in the UK it can be available through the NHS as a complementary therapy. It is more likely to be funded privately. However we do not have enough good quality evidence on how well it works for patients. We want to further explore the benefits, any potential pitfalls and what place it has in health settings.

This study is about listening to people with experience of hypnosis in breast cancer care in the UK to add to and improve our knowledge on the subject. As a University professional doctorate psychotherapy research study, its aim is to carefully, and sensitively learn about the personal experience of women who have received hypnosis in breast cancer care.

There are two research groups for the study:

Participants, group 1. Women diagnosed with breast cancer who, in the last 5 years, have received hypnosis for cancer related pain (e.g. emotional distress, anxiety, fear, grief, trauma, loss, anguish, etc., and or any physical pain).

Participants, group 2. Hypnotists/hypnotherapists who have used hypnosis in the UK within the last five years for women diagnosed with breast cancer. Specifically for cancer related emotional and or physical pain.

Anonymity for all participants is assured.

Please get in touch with Bryn Higgott at [email protected] if you fit the above criteria and are interested in attending on online interview. Deadline for interviews is 29th February 2024.

(Ethics approval information: UCLan Ethics approval number is: Health 0379FR. The NHS have given Advisory Board approval to proceed as not requiring NHS ethics approval. This has already been supplied to the Ethics Committee and is not required for resubmission.)